Get the Stockscreener App
712.39
0.30%
-2.16
After Hours:
712.39
Idexx Laboratories Inc stock is traded at $712.39, with a volume of 542.77K.
It is down -0.30% in the last 24 hours and up +0.81% over the past month.
Idexx Laboratories primarily develops, manufactures, and distributes diagnostic products, equipment, and services for pets and livestock. Its key product lines include single-use canine and feline test kits that veterinarians can employ in the office, benchtop chemistry and hematology analyzers for test-panel analysis on-site, reference lab services, and tests to detect and manage disease in livestock. The firm also offers vet practice management software and consulting services to animal hospitals. Idexx derives roughly 35% of its revenue from outside the United States.
See More
Previous Close:
$714.55
Open:
$707.29
24h Volume:
542.77K
Relative Volume:
1.02
Market Cap:
$56.89B
Revenue:
$4.17B
Net Income/Loss:
$1.03B
P/E Ratio:
56.47
EPS:
12.6148
Net Cash Flow:
$940.22M
1W Performance:
+5.30%
1M Performance:
+0.81%
6M Performance:
+32.21%
1Y Performance:
+64.77%
1-Day Range:
$694.52
$713.99
1-Week Range:
$661.89
$724.99
52-Week Range:
$356.14
$769.98
Idexx Laboratories Inc Stock (IDXX) Company Profile
Name
Idexx Laboratories Inc
Sector
Industry
Phone
(207) 556-0300
Address
ONE IDEXX DRIVE, WESTBROOK, ME
Compare IDXX with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
IDXX
Idexx Laboratories Inc
|
712.39 | 57.06B | 4.17B | 1.03B | 940.22M | 12.61 |
|
TMO
Thermo Fisher Scientific Inc
|
606.50 | 231.87B | 43.74B | 6.58B | 6.11B | 17.31 |
|
DHR
Danaher Corp
|
235.00 | 166.39B | 24.27B | 3.50B | 5.02B | 4.8589 |
|
IQV
Iqvia Holdings Inc
|
243.19 | 41.60B | 15.90B | 1.28B | 2.21B | 7.2842 |
|
A
Agilent Technologies Inc
|
145.76 | 41.90B | 6.95B | 1.30B | 1.15B | 4.5696 |
Idexx Laboratories Inc Stock (IDXX) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Dec-09-25 | Initiated | Barclays | Overweight |
| Oct-31-25 | Upgrade | Stifel | Hold → Buy |
| Oct-01-25 | Initiated | UBS | Neutral |
| Aug-05-25 | Reiterated | BTIG Research | Buy |
| Jul-01-25 | Initiated | Jefferies | Buy |
| Dec-02-24 | Initiated | Leerink Partners | Outperform |
| Jul-25-24 | Initiated | BTIG Research | Buy |
| Jan-30-24 | Downgrade | Piper Sandler | Overweight → Neutral |
| Dec-07-23 | Initiated | Exane BNP Paribas | Outperform |
| Dec-04-23 | Upgrade | Cleveland Research | Neutral → Buy |
| Aug-02-23 | Downgrade | Atlantic Equities | Overweight → Neutral |
| Jul-25-22 | Downgrade | Stifel | Buy → Hold |
| Jul-21-22 | Upgrade | Goldman | Neutral → Buy |
| Jul-12-22 | Initiated | Piper Sandler | Overweight |
| May-05-22 | Downgrade | BofA Securities | Buy → Neutral |
| Feb-08-22 | Initiated | Atlantic Equities | Overweight |
| Nov-18-21 | Initiated | Morgan Stanley | Overweight |
| Aug-05-21 | Resumed | Credit Suisse | Outperform |
| Jul-12-21 | Downgrade | Guggenheim | Buy → Neutral |
| Feb-17-21 | Initiated | Barclays | Overweight |
| Sep-09-19 | Initiated | Goldman | Neutral |
| May-23-19 | Initiated | Guggenheim | Buy |
| Nov-02-18 | Reiterated | BofA/Merrill | Buy |
| May-07-18 | Reiterated | Stifel | Buy |
| Jan-16-18 | Initiated | Piper Jaffray | Overweight |
| Aug-23-17 | Upgrade | BofA/Merrill | Neutral → Buy |
| Jul-28-17 | Upgrade | CL King | Neutral → Buy |
| Feb-03-17 | Downgrade | Feltl & Co. | Hold → Sell |
| Sep-29-16 | Resumed | BofA/Merrill | Neutral |
| Aug-16-16 | Reiterated | Stifel | Buy |
| Aug-03-16 | Upgrade | Northcoast | Sell → Neutral |
| Jul-20-16 | Reiterated | Canaccord Genuity | Buy |
| Apr-19-16 | Reiterated | Canaccord Genuity | Buy |
| Apr-01-16 | Initiated | CL King | Neutral |
| Mar-21-16 | Reiterated | Stifel | Buy |
| Feb-04-16 | Initiated | Credit Suisse | Outperform |
| Oct-29-15 | Reiterated | Stifel | Buy |
| Aug-28-15 | Downgrade | Raymond James | Outperform → Mkt Perform |
| Aug-13-15 | Reiterated | Stifel | Buy |
| Jul-23-15 | Reiterated | Canaccord Genuity | Buy |
View All
Idexx Laboratories Inc Stock (IDXX) Latest News
Is IDEXX Laboratories Inc. (IX1) stock at risk of policy regulationMarket Performance Summary & Real-Time Chart Pattern Alerts - ulpravda.ru
How IDEXX Laboratories Inc. stock trades before earningsAnalyst Downgrade & Real-Time Sentiment Analysis - ulpravda.ru
Is IDEXX Laboratories Inc. (IX1) stock undervalued historicallyJuly 2025 Rallies & Expert Approved Trade Ideas - ulpravda.ru
Will IDEXX Laboratories Inc. stock deliver consistent dividends2025 Market Trends & Weekly High Conviction Ideas - ulpravda.ru
Is IDEXX Laboratories Inc. stock attractive after correction2025 Earnings Surprises & AI Powered Market Entry Strategies - ulpravda.ru
Can IDEXX Laboratories Inc. (IX1) stock deliver double digit returnsQuarterly Risk Review & Capital Efficient Trading Techniques - ulpravda.ru
Veterinary Infectious Disease Diagnostics Market Forecast, 2025-2035, Featuring IDEXX Labs, Zoetis, Thermo Fisher Scientific, Virbac, bioMerieux and More - Yahoo Finance
Palo Alto, Capital One Financial, IDEXX Laboratories And Others: CNBC's 'Closing Trades' - Bitget
Palo Alto, Capital One Financial, IDEXX Laboratories And More: CNBC's 'Final Trades' - Benzinga
Is the current sentiment towards IDEXX Laboratories Inc positive or negative in the market? - Bitget
Final Trades: Palo Alto Networks, Capital One, Idexx Labs and the XLB - CNBC
Is the Market Bullish or Bearish on IDEXX Laboratories Inc? - Benzinga
IDEXX Stock Up 64.7% in a Year: What's Driving the Growth? - Your Wyoming Link
What catalysts could drive IDEXX Laboratories Inc. stock higher2026 world cup usa national team third place match young talents set piece tactics winner prediction tactical review - ulpravda.ru
IDEXX Laboratories Inc. stock outperforms competitors on strong trading day - MarketWatch
What to expect from IDEXX Laboratories’ next quarterly earnings report - MSN
2026 world cup key players explained: Can IDEXX Laboratories Inc. stock deliver surprise earnings beat2026 world cup usa national team round of 16 playmakers high defensive line odds analysis preview - ulpravda.ru
IDEXX Laboratories' SWOT analysis: stock outlook amid vet visit trends - MSN
What to Expect From IDEXX Laboratories’ Next Quarterly Earnings Report? - inkl
Railway Pension Investments Ltd Has $189.45 Million Stake in IDEXX Laboratories, Inc. $IDXX - MarketBeat
IDEXX Laboratories, Inc. $IDXX Shares Acquired by Allspring Global Investments Holdings LLC - MarketBeat
IDEXX Laboratories: How a Quiet Diagnostics Giant Is Rewriting the Future of Animal Health - AD HOC NEWS
IDEXX Laboratories, Inc. (NASDAQ:IDXX) Receives Average Recommendation of "Moderate Buy" from Brokerages - MarketBeat
IDEXX Laboratories (NASDAQ:IDXX) Upgraded at Wall Street Zen - MarketBeat
Published on: 2026-01-03 12:35:09 - moha.gov.vn
IDEXX Laboratories Inc. (IDXX) Stock Price | Live Quotes & Charts | NASDAQ - StocksToTrade
ETF Watch: Is IDEXX Laboratories Inc IX1 stock undervalued historically2025 Historical Comparison & Weekly High Return Stock Forecasts - moha.gov.vn
Here's How Much $1000 Invested In IDEXX Laboratories 10 Years Ago Would Be Worth Today - Sahm
Lazard Freres Gestion S.A.S. Sells 12,205 Shares of IDEXX Laboratories, Inc. $IDXX - MarketBeat
Ninety One UK Ltd Sells 22,366 Shares of IDEXX Laboratories, Inc. $IDXX - MarketBeat
Ninety One SA PTY Ltd Sells 4,317 Shares of IDEXX Laboratories, Inc. $IDXX - MarketBeat
Tikehau Investment Management Decreases Position in IDEXX Laboratories, Inc. $IDXX - MarketBeat
VIRGINIA RETIREMENT SYSTEMS ET Al Has $49.07 Million Stake in IDEXX Laboratories, Inc. $IDXX - MarketBeat
Investors in IDEXX Laboratories (NASDAQ:IDXX) have seen respectable returns of 65% over the past year - simplywall.st
IDEXX Laboratories (NASDAQ:IDXX) shareholders have earned a 65% return over the last year - Yahoo Finance
Zacks Industry Outlook Highlights Veracyte, IDEXX Laboratories and Intuitive Surgical - Nasdaq
Ethic Inc. Acquires 1,799 Shares of IDEXX Laboratories, Inc. $IDXX - MarketBeat
Is IDEXX Laboratories (IDXX) Stock Outpacing Its Medical Peers This Year? - sharewise.com
Three Seasons Wealth LLC Takes Position in IDEXX Laboratories, Inc. $IDXX - MarketBeat
$100 Invested In IDEXX Laboratories 20 Years Ago Would Be Worth This Much Today - Sahm
Precision Trading with Idexx Laboratories Inc. (IDXX) Risk Zones - Stock Traders Daily
BankPlus Trust Department Purchases 1,830 Shares of IDEXX Laboratories, Inc. $IDXX - MarketBeat
Swedbank AB Purchases 2,107 Shares of IDEXX Laboratories, Inc. $IDXX - MarketBeat
IDEXX Laboratories, Inc. $IDXX Shares Acquired by Beacon Investment Advisory Services Inc. - MarketBeat
IDEXX Laboratories Inc. stock underperforms Tuesday when compared to competitors - MSN
Vontobel Holding Ltd. Has $94.16 Million Position in IDEXX Laboratories, Inc. $IDXX - MarketBeat
Friedenthal Financial Buys New Stake in IDEXX Laboratories, Inc. $IDXX - MarketBeat
Westwind Capital Decreases Stake in IDEXX Laboratories, Inc. $IDXX - MarketBeat
Osaic Holdings Inc. Has $6.31 Million Stock Position in IDEXX Laboratories, Inc. $IDXX - MarketBeat
Idexx Laboratories director sells $1.4 million in shares - MSN
Riverbridge Partners LLC Reduces Holdings in IDEXX Laboratories, Inc. $IDXX - MarketBeat
Idexx Laboratories Inc Stock (IDXX) Financials Data
Revenue
Net Income
Cash Flow
EPS
0.45%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):